Empirical Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Empirical Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,083	Closed	-$202K	–	459
2026 Q1	$202K	Buy	+5,083	New	+$130K	0.05%	372

Empirical Asset Management's CNTA Position: Q2 2026 in Review

Empirical Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 5,083 shares — an estimated $202K sold.

Empirical Asset Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $202K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Empirical Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Empirical Asset Management sold 5,083 Centessa Pharmaceuticals shares in Q2 2026, an estimated $202K.
Empirical Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Empirical Asset Management's Centessa Pharmaceuticals position peaked at $202K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.